E2F3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.330000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.339400E-01
Normal-vs-Stage2
5.092800E-01
Normal-vs-Stage3
2.882000E-01
Normal-vs-Stage4
7.798600E-01
Stage1-vs-Stage2
3.761600E-01
Stage1-vs-Stage3
7.307400E-01
Stage1-vs-Stage4
9.370200E-02
Stage2-vs-Stage3
2.614800E-01
Stage2-vs-Stage4
2.462600E-01
Stage3-vs-Stage4
1.444630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.221800E-01
Normal-vs-AfricanAmerican
7.048000E-01
Normal-vs-Asian
4.417000E-01
Caucasian-vs-AfricanAmerican
5.937400E-01
Caucasian-vs-Asian
8.674600E-01
AfricanAmerican-vs-Asian
5.843200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.318600E-01
Normal-vs-Female
4.601200E-01
Male-vs-Female
5.596600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.315200E-01
Normal-vs-Age(41-60Yrs)
6.445800E-01
Normal-vs-Age(61-80Yrs)
3.427600E-01
Normal-vs-Age(81-100Yrs)
7.146200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.188600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.786800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.120800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.206100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.999000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.578000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.195600E-01
Normal-vs-Daily Drinker
1.110820E-01
Normal-vs-Weekly Drinker
7.002800E-01
Normal-vs-Occasional Drinker
3.320400E-01
Normal-vs-Social Drinker
6.109000E-01
Non Drinker-vs-Daily Drinker
2.107800E-01
Non Drinker-vs-Weekly Drinker
2.755800E-01
Non Drinker-vs-Occasional Drinker
8.985400E-01
Non Drinker-vs-Social Drinker
3.597000E-01
Daily Drinker-vs-Weekly Drinker
3.899900E-02
Daily Drinker-vs-Occasional Drinker
1.986630E-01
Daily Drinker-vs-Social Drinker
5.233800E-02
Weekly Drinker-vs-Occasional Drinker
3.520000E-01
Weekly Drinker-vs-Social Drinker
8.534000E-01
Occasional Drinker-vs-Social Drinker
4.464600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.314800E-01
Normal-vs-Grade 2
1.418050E-01
Normal-vs-Grade 3
1.748450E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.199900E-02
Grade 1-vs-Grade 3
2.000000E-02
Grade 1-vs-Grade 4
6.314800E-01
Grade 2-vs-Grade 3
6.430800E-01
Grade 2-vs-Grade 4
1.418050E-01
Grade 3-vs-Grade 4
1.748450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.872200E-01
Normal-vs-NonDiabetic
3.729400E-01
Diabetic-vs-NonDiabetic
7.045200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.501200E-01
Normal-vs-NoPancreatitis
3.986200E-01
Pancreatitis-vs-NoPancreatitis
9.756400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.063200E-01
Normal-vs-N1
5.322400E-01
N0-vs-N1
2.064600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.335200E-01
Normal-vs-TP53-NonMutant
3.639400E-01
TP53-Mutant-vs-TP53-NonMutant
1.009830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
